Concentrix stock (US20602D1019): Short interest stays elevated
Concentrix (CNXC) continues to attract high short interest, with 11.12 million shares or 18.39% of the public float as of April 30, 2026. The company provides customer experience and business services outsourcing, making it a proxy for corporate spending on service operations. Investors are focused on margin discipline, integration execution, and demand trends, as high short interest can increase volatility especially with upcoming operating updates and guidance changes.
AQR Holdings reports 4,831,868 Concentrix shares (CNXC) — 7.94%
AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have reported beneficial ownership of 4,831,868 shares of Concentrix (CNXC) common stock, which represents 7.94% of the class. This filing indicates shared voting power of 4,756,220 shares and shared dispositive power of 4,831,868 shares. The disclosure is made via a Schedule 13G filing, emphasizing a passive investment rather than an intent to control the company.
Concentrix Corp stock (US20602D1019): Employee count rises to 455,000
Concentrix Corp (NASDAQ: CNXC) reported an increase in its workforce to 455,000 employees as of November 30, 2025, marking a 1.11% year-over-year growth. This expansion reflects the company's scaling operations in global customer experience services, driven by managed service contracts, analytics platforms, and AI automation tools. The company traded at $31.52 USD on Nasdaq as of March 20, 2026, and its growth is significant for US investors tracking the service sector and outsourced customer experience trends.
Vanguard Group Inc. Sells 124,473 Shares of Concentrix Corporation $CNXC
Vanguard Group Inc. reduced its stake in Concentrix Corporation ($CNXC) by 2.5% in the fourth quarter, selling 124,473 shares, leaving them with 4.93 million shares valued at approximately $205.1 million. Analysts maintain a "Hold" rating on CNXC with an average target price of $48.50, despite the company reporting mixed Q4 2025 earnings where revenue beat expectations but EPS slightly missed. Concentrix also offers a quarterly dividend of $0.36 per share, yielding 5.9%.
Concentrix Corp stock (US20602D1019): Hits 52-week low amid AI concerns
Concentrix Corp (NASDAQ: CNXC) stock recently hit a 52-week low of 22.85 USD due to investor concerns about AI disrupting its customer experience services. The decline reflects broader anxieties about AI's impact on Concentrix's business model, with the stock previously trading around 60 USD in July 2025. Despite challenges, Concentrix remains a key player in outsourced CX, offering technology-enabled solutions and serving major tech and financial firms.
Concentrix Corporation (NASDAQ:CNXC) Given Average Rating of "Hold" by Analysts
Concentrix Corporation (NASDAQ:CNXC) has received an average "Hold" rating from analysts, with a mixed distribution of ratings and an average 1-year price target of $48.50. The stock recently traded near its 52-week low after reporting quarterly EPS slightly below estimates. Notably, a major shareholder sold 6 million shares while the CFO acquired 2,500 shares, and institutional investors retain a significant stake.
Concentrix Corp stock hits 52-week low at 22.85 USD
Concentrix Corp (CNXC) stock has fallen to a new 52-week low of $22.85, representing a 57.31% decline over the past year and trading 63% below its 52-week high. Despite this, InvestingPro data suggests the stock is significantly undervalued, trading at 0.51 times book value and listed on their Most Undervalued list. The company recently reported Q1 2026 revenue of $2.5 billion, meeting expectations, though EPS slightly missed projections, and analysts have lowered price targets due to margin pressure.
Concentrix (CNXC) Slid Over AI Disruption Concerns
Concentrix (CNXC) shares recently declined due to market concerns about AI disruption to its core business, despite the company reporting strong Q1 2026 revenues of approximately $2.5 billion. FPA Queens Road Small Cap Value Fund, which holds a small position in CNXC, noted the market's apprehension regarding AI's impact on customer experience (CX) vendors and the company's accumulated debt from its WebHelp acquisition. While the fund acknowledged Concentrix's potential, it is rebalancing towards higher-quality holdings and believes other AI stocks offer better upside with less risk.
Concentrix executives line up five investor conference events
Concentrix (NASDAQ: CNXC) announced that its senior management will participate in five investor conferences between May and June 2026, including events hosted by Needham, J.P. Morgan, Barrington Research, Baird, and BofA Securities. These engagements will feature company presentations, fireside chats, and investor meetings for institutional investors. Presentation materials will be made available on the Concentrix investor relations website.
FMR LLC holds 6.9% of Concentrix Corp (NYSE: CNXC) on 03/31/2026
FMR LLC has reported a beneficial ownership of 4,223,281.76 shares, or 6.9%, of Concentrix Corp (NYSE: CNXC) common stock as of March 31, 2026. This passive institutional ownership, disclosed via a Schedule 13G filing, indicates sole dispositive power over all these shares and sole voting power over 4,210,007 shares. The filing emphasizes that this stake is held in the ordinary course of business and is not intended to change or influence company control.
CNXC SEC Filings - Concentrix 10-K, 10-Q, 8-K Forms
This page provides a comprehensive overview of Concentrix (CNXC) SEC filings, including annual reports (10-K), quarterly reports (10-Q), material event filings (8-K), and insider trading forms. It features AI-powered summaries for easier understanding of lengthy documents and real-time updates from the EDGAR system. The page also details recent insider transactions and financial disclosures from Concentrix, a Fortune 500 public company.
Concentrix Corporation (CNXC) Down Around 25% Since Q1 2026, Here’s What You Need to Know
Concentrix Corporation (CNXC) has seen its share price drop by over 25% since releasing its Q1 2026 earnings on March 24, now trading near all-time lows. Despite this, the average Street price target suggests a potential 49% upside. While revenue increased year-over-year, GAAP EPS missed expectations, primarily due to a significant decline in operating and net income, leading Bank of America Securities to lower its price target.
Concentrix Corporation (CNXC) Down Around 25% Since Q1 2026, Here’s What You Need to Know
Concentrix Corporation (NASDAQ: CNXC) has seen its share price drop by over 25% since releasing its fiscal Q1 2026 earnings on March 24, 2026, despite exceeding revenue consensus. The company's GAAP EPS fell short due to a significant decline in operating and net income, leading Bank of America Securities to lower its price target to $23 while maintaining a Neutral rating. Despite the recent dip, the Street's average price target suggests a potential upside of over 49% in the next 12 months.
Is It Too Late to Buy Concentrix Corp (CNXC) After 3.0% Rally? G
Concentrix Corp (CNXC) shares surged 3.0% to $24.53, yet remain significantly undervalued according to GuruFocus' GF Value™ of $62.29, which is 60.6% higher. Despite the attractive pricing and recent insider buying, the stock is flagged as a "Possible Value Trap" due to potential underlying issues and challenges in maintaining momentum. Investors should exercise caution while considering its strong profitability and low P/E ratio compared to historical levels.
GBL ownership drop leads Bilge Ogut to resign from Concentrix board
Bilge Ogut has resigned from the Board of Concentrix (CNXC) effective April 29, 2026. This resignation occurred because GBL reduced its beneficial ownership stake in Concentrix, falling below the Board Nomination Threshold specified in their Investor Rights Agreement. Consequently, Concentrix lost its right to nominate a board member.
GBL ownership change prompts Concentrix (NASDAQ: CNXC) board resignation
Concentrix Corporation reported a change in its Board of Directors following a transaction by Groupe Bruxelles Lambert SA (GBL) that reduced its beneficial ownership below a specified "Board Nomination Threshold." As a result, GBL's nominee, Bilge Ogut, resigned from the Concentrix Board and its committees, effective immediately on April 29, 2026. This change is tied to an Investor Rights Agreement established during Concentrix's September 2023 acquisition of Webhelp.
Groupe Bruxelles Lambert (CNXC) affiliates unload 6M Concentrix shares, keep 2.77M
Affiliates of Groupe Bruxelles Lambert, including FINPAR VI SA, FINPAR V SA, and Sapiens S.a r.l., executed an open-market sale of 6,000,000 shares of Concentrix Corp (CNXC) common stock at $22.25 per share on April 29, 2026. Following this significant transaction valued at $133.5 million, the reporting entities collectively retain indirect ownership of 2,773,667 Concentrix shares. This sale substantially reduces their holdings but leaves a notable remaining stake, with the filing indicating a "Very Negative" sentiment due to the large insider disposition.
Concentrix stock hits 52-week low at 24.26 USD
Concentrix Corporation's stock has reached a 52-week low of $24.23, reflecting a nearly 50% decline over the past year. Despite this downturn and some concerns over margin pressure from analysts, InvestingPro analysis suggests the stock may be undervalued given its 5.79% dividend yield and predicted profitability for the year. The company recently reported Q1 2026 revenue of $2.5 billion, meeting expectations, and reaffirmed its full-year guidance for 2.5% constant currency growth.
CNXC (NASDAQ: CNXC) files Form 144; affiliate move cites 8.7M shares
Concentrix Corp (NASDAQ: CNXC) has filed a Form 144, indicating a proposed sale of common stock by an affiliate. The filing, dated April 29, 2026, references 8,699,080 shares received on September 25, 2023, through a Share Purchase and Contribution Agreement from June 12, 2023. This Form 144 is a regulatory document that ensures transparency for large sales of company stock.
Groupe Bruxelles Lambert trims Concentrix (CNXC) stake with 6M-share Rule 144 sale
Groupe Bruxelles Lambert has significantly reduced its stake in Concentrix Corporation (CNXC) through a Rule 144 block trade. Its subsidiary, Sapiens S.à r.l., sold 6,000,000 shares at $22.25 each on April 29, 2026. This transaction reduced Groupe Bruxelles Lambert's beneficial ownership to 4.55% of Concentrix's outstanding shares, removing its Schedule 13D reporting obligations.
Synnex Technology (CNXC) holds 4.37M Concentrix shares via subsidiary
Synnex Technology International Corporation has filed an amended Schedule 13G, reporting beneficial ownership of 4,369,475 shares of Concentrix Corp. common stock, which represents 7.09% of the class. These shares are held through its wholly-owned subsidiary, Peer Developments Ltd., with Synnex retaining sole voting and dispositive power. The filing, signed by Director Tu, Shu-Wu on April 27, 2026, clarifies the ownership structure.
Cwm LLC Sells 49,042 Shares of Concentrix Corporation $CNXC
Cwm LLC significantly reduced its stake in Concentrix Corporation, selling 49,042 shares and retaining 37,468 shares valued at $1.56 million. Despite this institutional sell-off, company insiders, including the CFO and CEO, increased their holdings. Concentrix recently announced a quarterly dividend of $0.36 per share, contributing to an annualized yield of approximately 5.5%.
Copeland Capital Management LLC Has $45.28 Million Stock Position in Concentrix Corporation $CNXC
Copeland Capital Management LLC reduced its stake in Concentrix Corporation by 10% in the fourth quarter, now holding 1,088,922 shares valued at $45.28 million. Despite institutional investors owning 90.34% of the company, Concentrix faces mixed analyst sentiment, price target cuts, and financial challenges including a 1.43 debt-to-equity ratio and a negative net margin, though it did announce a quarterly dividend. Insiders have recently bought shares, with CEO Christopher A. Caldwell acquiring 1,000 shares and CFO Andre S. Valentine buying 2,500 shares.
Concentrix Corporation (NASDAQ:CNXC) Receives Consensus Rating of "Hold" from Analysts
Concentrix Corporation (NASDAQ:CNXC) has a consensus "Hold" rating from analysts, with a target price of $48.50. The company recently missed EPS expectations but saw a 5.4% increase in revenue year-over-year, despite a negative net margin and high debt-to-equity ratio. Insiders, including the CFO and CEO, have recently purchased shares, and the company declared a quarterly dividend of $0.36 per share.
Concentrix Corp (CNXC) Stock Up 6.7% and Still Undervalued -- GF Score: 63/100
Concentrix Corp (CNXC) shares surged 6.7% to $27.86, yet remain significantly undervalued according to GuruFocus's GF Value™ of $62.42. Despite a strong profitability score of 7/10 and recent insider buying, the company faces challenges in valuation and momentum, earning a GF Score™ of 63/100 and a "Possible Value Trap" label due to a 41.3% stock price decline over the past year.
Will Insider Buying Spree by Concentrix’s CFO Reshape Confidence in CNXC’s Management Narrative?
Concentrix Corp's CFO, Andre S. Valentine, recently purchased shares, increasing his direct holdings and signaling management's confidence. This insider buying, coupled with a lack of insider selling, is seen as a positive sign, particularly as the company has also been active in share repurchases. However, the article highlights the need for investors to consider the company's limited revenue growth and significant debt load against this backdrop of insider commitment and ongoing integration risks.
Concentrix Corp (CNXC) Shares Fall 8.4% -- What GF Score of 62 T
Concentrix Corp (CNXC) shares fell 8.4% to $26.12, but its GF Value of $62.35 suggests it is undervalued with a significant 58.1% upside, despite a "possible value trap" label. The company has a GF Score of 62/100, indicating above-average potential, driven by strong profitability but concerns in valuation and momentum. Recent insider buying activity, with no selling, hints at confidence in the company's future.
Concentrix (CNXC) CFO adds 2,500 shares in open-market trade
Concentrix (CNXC) Chief Financial Officer, Andre S. Valentine, recently purchased 2,500 shares of the company's Common Stock in an open-market transaction. The shares were acquired at an average price of $27.9477 each, increasing his direct holdings to 89,066 shares. This insider trade, reported via Form 4, signals positive sentiment from a key executive.
CNXC Financials: Revenue Breakdown, Margins & Competitor Comparison
This article provides a financial overview of Concentrix Corp (CNXC), detailing its revenue breakdown, profitability margins, and a comparison with competitors. The company's largest revenue contributor is Technology and consumer electronics, representing 27.4% of total sales. CNXC reports a gross margin of 33.98%, an operating margin of 6.62%, and a net margin of 0.86%, with a negative Return on Equity (ROE) of -38.94%. In comparison to competitors like ASGN and VOYG, CNXC shows a stronger gross margin.
Concentrix (NASDAQ: CNXC) grows Q1 revenue but profit, cash flow weaken
Concentrix (NASDAQ: CNXC) reported a 5.4% increase in Q1 revenue to $2.5 billion, driven by strength in retail, travel, e-commerce, banking, and communications sectors. However, the company's profit significantly declined, with net income falling to $21.6 million from $70.3 million a year earlier, and operating cash flow swung to an outflow of $83.2 million. This decline was attributed to gross margin compression, increased restructuring and integration expenses, a loss on assets held for sale, and substantial long-term debt.
Concentrix Corp. Experiences Revision in Its Stock Evaluation Amidst Market Challenges
Concentrix Corp. has seen a substantial decline in its stock value, dropping 59.38% over the past year, in sharp contrast to the S&P 500's gains. Technical indicators uniformly suggest a bearish outlook for the company, reflecting significant struggles to regain market traction amidst a challenging economic landscape. The stock has experienced even steeper declines over three and five-year periods.
Concentrix (CNXC) CEO Christopher Caldwell adds 1,000 shares
Concentrix Corp's President and CEO, Christopher A. Caldwell, purchased 1,000 shares of company common stock on March 26, 2026, at an average price of $26.97 per share in an open-market transaction. This purchase increases his direct ownership to 357,382 shares, signaling enhanced insider confidence in the company. The transaction was disclosed through a Form 4 filing with the SEC, which provides transparency into insider trading activities.
Concentrix (NASDAQ: CNXC) director receives 7,701-share restricted stock award
Jennifer Deason, a director at Concentrix (NASDAQ: CNXC), received an award of 7,701 restricted stock units (RSUs) as compensation, increasing her direct holdings to 17,704 shares. The RSUs were granted under the 2020 Stock Incentive Plan with no cash purchase price and will vest on the earlier of one year from the grant date or Concentrix’s 2027 Annual Meeting of Stockholders. This transaction is categorized as a compensation-related grant rather than an open-market purchase.
Concentrix (CNXC) director awarded 7,701 restricted stock units
Concentrix (CNXC) director Hayley Kathryn was awarded 7,701 restricted stock units under the company's 2020 Stock Incentive Plan. These units, granted at no cash cost, will vest on the earlier of one year from the grant date or the company’s 2027 Annual Meeting of Stockholders. After this transaction, Kathryn directly holds 17,712.1206 shares and indirectly holds 3,034.2930 shares through a trust.
Concentrix (CNXC) director Ann Vezina receives 7,701 RSU equity grant
Concentrix director Ann F. Vezina was granted 7,701 shares of Common Stock in the form of restricted stock units (RSUs) as part of the company's 2020 Stock Incentive Plan. This award, made at no cash price, increases her direct holdings to 19,648 shares. The RSUs will vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix’s 2027 Annual Meeting of Stockholders.
Concentrix Corp (CNXC) director Cheng Chih-Kai submits initial Form 3
Concentrix Corp director Cheng Chih-Kai has filed an initial Form 3, signaling his new status as an insider director of the company. This administrative filing does not indicate any beneficial ownership of securities, nor does it reflect any trading activity such as purchases, sales, or derivative exercises. The document primarily serves as an initial disclosure required by the SEC for new insiders.
Concentrix (CNXC) director LaVerne Council receives 7,701-share RSU award
Concentrix (CNXC) director LaVerne H. Council was granted 7,701 Restricted Stock Units (RSUs) as an equity award, increasing her direct holdings to 17,704 shares. These RSUs were issued at no cash exercise price and are set to vest on the earlier of the one-year anniversary of the grant date or the company's 2027 Annual Meeting of Stockholders. This award aligns director compensation with the long-term interests of shareholders.
Restricted stock grant increases Concentrix (NASDAQ: CNXC) director stake
Concentrix (NASDAQ: CNXC) director Bilge Ogut received a grant of 7,701 restricted stock units, as detailed in a recent Form 4 SEC filing. These units are an equity-based compensation and vest fully on the earlier of one year from the grant date or Concentrix's 2027 Annual Meeting. Following this award, Ogut directly holds 7,701 shares, aligning her interests with shareholders.
Cheng Chih-Kai receives 7,701 Concentrix Corp (CNXC) restricted stock units
Concentrix Corp director Cheng Chih-Kai was granted 7,701 restricted stock units (RSUs) of Common Stock at no cash purchase price, under the company’s 2020 Stock Incentive Plan. This award represents his entire direct holding after the transaction and is compensation-related, not an open-market purchase or sale. The RSUs will vest in full on the earlier of the one-year anniversary of the grant date or the date of Concentrix Corp's 2027 Annual Meeting of Stockholders.
Concentrix (NASDAQ: CNXC) investors approve 3.7M-share increase to 2020 stock plan
Concentrix (NASDAQ: CNXC) stockholders approved an amendment to the 2020 Stock Incentive Plan, increasing the number of shares available for issuance by 3,700,000. Additionally, shareholders elected nine directors, ratified Ernst & Young LLP as the independent auditor for fiscal year 2026, and approved the compensation of named executive officers on an advisory basis. These decisions were made at the company's 2026 annual meeting on March 25, 2026.
Vanguard realigns reporting; Concentrix (CNXC) ownership shown as 0 shares
The Vanguard Group has filed an amended Schedule 13G/A report for Concentrix Corp (CNXC), indicating 0 shares beneficially owned due to an internal realignment effective January 12, 2026. This administrative change means certain Vanguard subsidiaries will now report their beneficial ownership separately in accordance with SEC guidelines. The filing clarifies reporting attribution rather than describing a market transaction or sale of shares.
Concentrix Corp. Hits New 52-Week Low at $24.28 Amid Declining Confidence
Concentrix Corp. (CNXC) has hit a new 52-week low of $24.28, reflecting a significant 56.5% stock price decline over the past year. Despite consistent growth in net sales and operating profit, the company faces challenges including a high debt-to-equity ratio and a 13.18% reduction in promoter stake, indicating declining confidence. The company currently has a market capitalization of $1,972 million and a P/E ratio of 6.00.
Concentrix Corporation (NASDAQ:CNXC) Q1 2026 Earnings Call Transcript
Concentrix Corporation (NASDAQ:CNXC) reported Q1 2026 earnings, missing EPS expectations at $2.61 against an anticipated $2.65. Despite the slight miss, the company highlights significant growth in AI-driven solutions, with a 61% year-over-year increase in technology wins and a doubling of annual contract value for AI solutions quarter-on-quarter. The outlook for Q2 anticipates revenue between $2.46 billion and $2.485 billion, with executives expressing confidence in margin expansion in the latter half of 2026 and a commitment to reducing net leverage.
Concentrix Corporation (CNXC) Lags Q1 Earnings Estimates
Concentrix Corporation (CNXC) reported Q1 earnings of $2.61 per share, missing the Zacks Consensus Estimate of $2.64 per share. Despite the earnings miss, the company's revenues of $2.5 billion surpassed the Zacks Consensus Estimate by 0.51%. Concentrix shares have declined by 20.5% year-to-date, and the stock currently holds a Zacks Rank #3 (Hold).
These Analysts Cut Their Forecasts On Concentrix Following Q1 Results
Following its Q1 results, which showed mixed financial performance, Concentrix (NASDAQ: CNXC) has seen several analysts cut their price targets. Despite revenue slightly beating estimates, adjusted EPS missed, and the company issued Q2 guidance below expectations, leading to a 6.9% drop in its share price. Analysts from Baird, Canaccord Genuity, and Barrington Research maintained their ratings but significantly lowered their price targets for Concentrix.
BofA cuts Concentrix stock price target on margin pressure concerns
BofA Securities has lowered its price target for Concentrix Corp. (NASDAQ:CNXC) to $32 from $47 due to expected margin pressure, while maintaining a Neutral rating. The company's first-quarter revenue met the high end of guidance, but EPS of $2.61 fell short of BofA's estimates. Concentrix issued second-quarter guidance that was below Street expectations, and the stock is currently trading near its 52-week low.
Concentrix Corporation (NASDAQ:CNXC) to Issue Quarterly Dividend of $0.36
Concentrix Corporation (NASDAQ:CNXC) announced a quarterly dividend of $0.36 per share, to be paid on May 5th to shareholders of record on April 24th, representing a 5.4% yield and an 11.3% payout ratio. Despite revenue growth of 5.4% year-over-year in Q1 2026, the company experienced a significant decline in GAAP net income (down 69% YoY) and missed non-GAAP EPS estimates slightly, leading to a sharp sell-off in shares. The company highlighted ongoing share repurchases and commercial momentum in higher-value offerings, but also noted weakened profitability, compressed margins, and negative cash flow.
Canaccord cuts Concentrix stock price target on margin pressure
Canaccord has lowered its price target for Concentrix Corp. (NASDAQ:CNXC) to $55 from $80, while maintaining a Buy rating, due to margin compression and the market's skepticism about the company's second-half recovery promises. The company reported slightly lower-than-expected EPS but met revenue expectations for Q1 fiscal year 2026, with adjusted EBITDA margins compressing by about 200 basis points year-over-year. Despite the stock's significant decline, it trades at an attractive EV/EBITDA of 5.03, and the firm views the first quarter's performance as largely in-line with expectations.
Core & Main, Concentrix And 3 Stocks To Watch Heading Into Tuesday
As U.S. stock futures showed a downward trend on a Tuesday morning, several companies including Core & Main, Concentrix, and GameStop are in focus for investors. Core & Main and Concentrix are expected to release their quarterly earnings, while Slide Insurance Holdings announced a new share buyback program. Applied Optoelectronics received a significant order from a major hyperscaler.
Concentrix Corp (CNXC) Q1 2026 Earnings Call Highlights: Strong AI Adoption and Banking Growth
Concentrix Corp (CNXC) reported a 1.9% constant currency revenue increase and a 61% jump in technology wins for Q1 2026, with AI-related bookings more than doubling and banking revenue up 13%. Despite strong AI adoption and growth in banking, the company experienced a negative free cash flow of $145 million due to increased accounts receivable and margin compression in some verticals. Concentrix projects margin improvement in the second half of the year through cost actions and scale from transformational deals.
